Rajarshi Chattaraj

Rajarshi Chattaraj received his PhD from the University of Colorado Boulder with Prof. Andrew Goodwin. In his PhD work, he engineered the interfacial chemistries of perfluorocarbon, hydrocarbon, and liquid crystal nanodroplets using phospholipids, proteins, and oligonucleotides to make the droplets responsive to different stimuli, to detect cancer biomarkers in situ. As a postdoc at the University of Pennsylvania with Profs. Daniel Hammer and Daeyeon Lee, he designed variants of recombinant proteins to inactivate the SARS-CoV-2 virus. He also developed therapeutic gas microbubbles to respond to ultrasound and treat and preserve the cerebral vasculature after traumatic brain injury. His research interests lie in the interfacial design of self-assembling colloids and nanostructures for applications in a variety of medical applications, including ultrasound imaging and therapy, diagnostic assays, and treatment of infectious diseases.

Ph.D.; University of Colorado at Boulder; Mechanical Engineering; 2018

B.Tech.; National Institute of Technology; Chemical Engineering; 2012

https://research.njit.edu/chattaraj/

BME 491 - RESEARCH & INDEPENDENT STUDY I

BME 420 - ADV BIOMATERIALS SCIENCE

BME 420: Advanced Biomaterials Science

Ultrasound; Brain Injury; Protein Engineering; Infectious Diseases; Biosensing; Colloidal and Nanoparticle Self Assembly.